Diversa in R&D agreement with Glaxo

DVSA and Glaxo Wellcome (GLX; LSE:GLXO) will screen small molecule therapeutics from DVSA's PathwayLibraries, which contain small molecule candidates derived from DNA analysis of environmental sources...